Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-25 @ 8:23 PM
Study NCT ID:
NCT02149069
Status:
UNKNOWN
Last Update Posted:
2015-08-03
First Post:
2014-05-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Blood Management Program in the Post - Operative Period.
Sponsor:
Azienda USL Reggio Emilia - IRCCS
Organization:
Study Overview
Official Title:
Blood Management Program: Appropriateness of Transfusion Therapy in the Post - Operative Period.
Status:
UNKNOWN
Status Verified Date:
2015-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A care path in the field of transfusion medicine was creates at ASMN - IRCCS addressed to patients undergoing complex surgical procedures.
Detailed Description:
This pathway is called Blood Management Program (BMP).
The implementation of this process should improve transfusion therapy in the peri-operative period in order to:
* correct the transfusional approach to surgical patients
* optimize the management of transfusional resources (red blood cells, plasma, platelets)
* optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood
The implementation of this process should improve transfusion therapy in the peri-operative period in order to:
* correct the transfusional approach to surgical patients
* optimize the management of transfusional resources (red blood cells, plasma, platelets)
* optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: